Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896422009> ?p ?o ?g. }
- W2896422009 endingPage "1201" @default.
- W2896422009 startingPage "1186" @default.
- W2896422009 abstract "The prevalence of auto-antibodies associated to pulmonary arterial hypertension in scleroderma patients was reviewed, based on reports cited in two major scientific databases. Data were collected on the following types of antibodies: antinuclear, anti-double-stranded DNA, anticentromere, anti-CENP-A, anti-CENP-B, anti-bicaudal D2, anti-nucleolar, anti-Scl-70 (anti-topoisomerase I), anti-topoisomerase II α, anti-RNP, anti-U1RNP, anti-U3RNP, anti-RNA polymerase III, anti-Th/To, anti-histone, antiphospholipid, anti-PmScl, anti-Sm, anti SSA (anti-Ro),anti SSB (La), anti-Ro52 (TRIM 21), anti-Ku, anti-B23, anti-RuvBL1, anti-RuvBL2, anti-fibrin bound tissue plasminogen activator, anti-endothelial cell, anti-phosphatidylserine-prothrombin complex, anti-endothelin-1 type A receptor, anti-angiotensin II type 1 receptor, anti‑carbonic anhydrase II, anti-fibroblast, anti-cyclic citrullinated peptide, anti-4-sulfated N-Acetyl-lactosamine, class I and II anti-human leukocyte antigen. Auto-antibodies were shown by different authors to be associated to this condition, with different prevalence values for each type of auto-antibody. Antinuclear antibodies, anti-centromere antibodies, antiphospholipid antibodies, anti-U3 RNP antibodies and anti-Th/To antibodies would appear to show a particularly important prevalence in scleroderma patients with pulmonary hypertension, appearing in about 8/10 (antinuclear), 1/ 2 (anti-centromere, anti-phospholipid), and 1/4 (anti-U3RNP, anti-Th/To) of patients. The available evidence points in the direction of a strong association between auto-immune mechanisms and pulmonary hypertension in the setting of scleroderma." @default.
- W2896422009 created "2018-10-26" @default.
- W2896422009 creator A5001428622 @default.
- W2896422009 creator A5014800035 @default.
- W2896422009 creator A5022434142 @default.
- W2896422009 creator A5027413173 @default.
- W2896422009 creator A5031423356 @default.
- W2896422009 creator A5037791544 @default.
- W2896422009 creator A5044525670 @default.
- W2896422009 creator A5087337932 @default.
- W2896422009 date "2018-12-01" @default.
- W2896422009 modified "2023-10-10" @default.
- W2896422009 title "Prevalence of auto-antibodies associated to pulmonary arterial hypertension in scleroderma – A review" @default.
- W2896422009 cites W125767562 @default.
- W2896422009 cites W1517878023 @default.
- W2896422009 cites W1541316315 @default.
- W2896422009 cites W1572813974 @default.
- W2896422009 cites W1582069062 @default.
- W2896422009 cites W1595501421 @default.
- W2896422009 cites W1896799110 @default.
- W2896422009 cites W1965264094 @default.
- W2896422009 cites W1967793101 @default.
- W2896422009 cites W1969956043 @default.
- W2896422009 cites W1971569946 @default.
- W2896422009 cites W1971733159 @default.
- W2896422009 cites W1981106194 @default.
- W2896422009 cites W1981150012 @default.
- W2896422009 cites W1983204429 @default.
- W2896422009 cites W1984467424 @default.
- W2896422009 cites W1986616087 @default.
- W2896422009 cites W1996242001 @default.
- W2896422009 cites W2011178910 @default.
- W2896422009 cites W2013169184 @default.
- W2896422009 cites W2014892375 @default.
- W2896422009 cites W2016801324 @default.
- W2896422009 cites W2018426574 @default.
- W2896422009 cites W2019029063 @default.
- W2896422009 cites W2020798696 @default.
- W2896422009 cites W2022351792 @default.
- W2896422009 cites W2026428479 @default.
- W2896422009 cites W2029802993 @default.
- W2896422009 cites W2036640242 @default.
- W2896422009 cites W2039685181 @default.
- W2896422009 cites W2040235061 @default.
- W2896422009 cites W2041467216 @default.
- W2896422009 cites W2045844891 @default.
- W2896422009 cites W2052472503 @default.
- W2896422009 cites W2064213190 @default.
- W2896422009 cites W2067873825 @default.
- W2896422009 cites W2069650976 @default.
- W2896422009 cites W2081028616 @default.
- W2896422009 cites W2083348598 @default.
- W2896422009 cites W2083719119 @default.
- W2896422009 cites W2090913597 @default.
- W2896422009 cites W2094053642 @default.
- W2896422009 cites W2101176542 @default.
- W2896422009 cites W2101469388 @default.
- W2896422009 cites W2105316222 @default.
- W2896422009 cites W2111914290 @default.
- W2896422009 cites W2114553628 @default.
- W2896422009 cites W2121185030 @default.
- W2896422009 cites W2121599003 @default.
- W2896422009 cites W2121932914 @default.
- W2896422009 cites W2122416783 @default.
- W2896422009 cites W2128153803 @default.
- W2896422009 cites W2128547912 @default.
- W2896422009 cites W2130932769 @default.
- W2896422009 cites W2132078597 @default.
- W2896422009 cites W2142848427 @default.
- W2896422009 cites W2146597908 @default.
- W2896422009 cites W2152024314 @default.
- W2896422009 cites W2154622998 @default.
- W2896422009 cites W2156628000 @default.
- W2896422009 cites W2157046471 @default.
- W2896422009 cites W2158974767 @default.
- W2896422009 cites W2161868870 @default.
- W2896422009 cites W2164197618 @default.
- W2896422009 cites W2170474956 @default.
- W2896422009 cites W2294470418 @default.
- W2896422009 cites W2315097289 @default.
- W2896422009 cites W2395479852 @default.
- W2896422009 cites W2418286583 @default.
- W2896422009 cites W2468377255 @default.
- W2896422009 cites W2507375103 @default.
- W2896422009 cites W2508060872 @default.
- W2896422009 cites W2551702573 @default.
- W2896422009 cites W2556468480 @default.
- W2896422009 cites W2564046483 @default.
- W2896422009 cites W2567594725 @default.
- W2896422009 cites W2575273423 @default.
- W2896422009 cites W2620051763 @default.
- W2896422009 cites W2734845466 @default.
- W2896422009 cites W2740987426 @default.
- W2896422009 cites W2793231800 @default.
- W2896422009 cites W38740083 @default.
- W2896422009 cites W4244498544 @default.
- W2896422009 doi "https://doi.org/10.1016/j.autrev.2018.06.009" @default.
- W2896422009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30316987" @default.